Search

Displaying results 9621 - 9630 of 10000 in total
  1. Drug

    Filociclovir

    go.drugbank.com/drugs/DB12438
    Investigational

    Filociclovir is under investigation in clinical trial NCT01433835 (Safety and Pharmacokinetics of Single Oral Doses of Filociclovir in Healthy Volunteers).

  2. Drug

    Ianalumab

    go.drugbank.com/drugs/DB16666
    Investigational

    Ianalumab is under investigation in clinical trial NCT01930175 (Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris).

  3. Drug

    JNJ-55308942

    go.drugbank.com/drugs/DB19110
    Investigational

    JNJ-55308942 is under investigation in clinical trial NCT05328297 (A Study of JNJ-55308942 in the Treatment of Bipolar Depression).

  4. Drug

    Virginiamycin S1

    go.drugbank.com/drugs/DB04805
    Experimental

    One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others. … It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.

  5. Drug

    Tulrampator

    go.drugbank.com/drugs/DB16344
    Investigational

    Tulrampator is under investigation in clinical trial NCT02626572 (Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive

  6. Drug

    ZR202-CoV

    go.drugbank.com/drugs/DB27995
    Investigational

    ZR202-CoV is under investigation in clinical trial NCT05490108 (Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.).

  7. Drug

    ACCG-2671

    go.drugbank.com/drugs/DB33945
    Experimental

    ACCG-2671 is under investigation in clinical trial NCT07815678 (First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671).

  8. Drug

    Vopratelimab

    go.drugbank.com/drugs/DB15378
    Investigational

    Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).

  9. Drug

    Alamifovir

    go.drugbank.com/drugs/DB06368
    Experimental

    Alamifovir is an antiviral agent specific for HBV.

  10. Drug

    Tesaglitazar

    go.drugbank.com/drugs/DB06536
    Investigational

    Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. … Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.